-
Posted by
Two Blokes Wed at 2:15 PM -
Filed in
Stock
-
0 views
U.S.-listed shares of GSK (GSK) are gaining in premarket trading Wednesday after the British pharma giant posted better-than-expected first-quarter results and said it was "well positioned" should the Trump administration imposes tariffs against the industry.